Imagine tracking cancer the same way we track cholesterol or blood sugar—with a routine blood test. The standard for cancer detection has relied on scans and tissue biopsies for decades. They work—but they’re invasive, expensive, and they only show one snapshot in time. Now, scientists are exploring a different idea: what if cancer leaves clues behind in the blood that we can read early and repeatedly?
The U.S. Food and Drug Administration announced that it is taking action to advance sunscreen innovation, part of a broader initiative in the Office of Nonprescription Drugs. The agency is proposing to add bemotrizinol as a permitted active ingredient for use in sunscreens. Based on the data reviewed by the FDA, bemotrizinol provides protection against both...
The U.S. Food and Drug Administration recently approved two new oral medicines to treat a common sexually transmitted infection called gonorrhea. The FDA today approved Nuzolvence (zoliflodacin) granules that dissolve in water. This medicine can treat uncomplicated urogenital gonorrhea in adults and children 12 years and older who weigh at least 77 pounds....
What is it prescribed for? MYQORZO is used to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). This is a heart condition where the heart muscle becomes too thick and blocks blood flow out of the heart, making it hard to exercise or even do daily activities. It was approved by the FDA December 2025. MYQORZO is prescribed to help: Improve...
Cancer doctors have long relied on scans and tissue biopsies to diagnose and track cancer. While these tools are important, they can be invasive, expensive, and may not always show how cancer is changing in real time. New research suggests that biomarkers that are proteins and RNA found in the blood could offer a simpler way to detect cancer earlier and monitor it...
For decades, cancer detection has relied on imaging tests and tissue biopsies. While powerful, those tools can be invasive and don’t always show how cancer is changing in real time. Scientists are now focusing on something called circulating tumor cells, or CTCs — these are tumor cancer cells floating in the bloodstream and the ability to detect these may completely change how we diagnose and monitor cancer. #cancer #science